Related Experiment Video
Updated: Jul 28, 2026

08:12
Isolation of Leukocytes from Human Breast Milk for Use in an Antibody-dependent Cellular Phagocytosis Assay of HIV Targets
Published on: September 6, 2019
The neonate's immunity gap, breast feeding and cot death
Lancet (London, England)
|February 22, 1975
Summary
Infant milk provides crucial immunological support during a vulnerable transition period. Potential immune system defaults, including lack of breastfeeding, may contribute to cot death risk.
Area of Science:
- Immunology
- Neonatal Health
- Mammalian Infant Behavior
Background:
- Infants rely on maternal milk for nutrition and immunological development.
- This period is critical as infants transition from fetal isolation to independent immune defense.
- Sudden infant death syndrome (cot death) predominantly occurs during this vulnerable phase.
Purpose of the Study:
- To explore the role of immunological components in maternal milk.
- To investigate potential immune system defaults as a contributing factor to cot death.
- To analyze diverse risk factors for cot death through the lens of immune function.
Main Methods:
- Review of mammalian infant feeding behaviors.
- Analysis of immunological functions of maternal milk.
- Statistical examination of cot death risk factors and their relation to immune competence.
Main Results:
- Maternal milk's immunological components are vital for infant immune system augmentation.
- Several risk factors for cot death, including reduced breastfeeding, may represent immune defaults.
- These defaults, potentially combined with other mechanisms, could underlie cot death.
Conclusions:
- An immune mechanism is proposed as a potential underlying factor in cot death.
- Interpreting cot death risk factors as immune defaults offers a new perspective.
- Further research into infant immunity and cot death is warranted.
Related Concept Videos
Transcytosis of IgG
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Active versus Passive Immunity
Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
Active Immunity
Active immunity refers to the resistance one develops...
Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...

